Brain CT-scan in acute stroke patients: silent infarcts and relation to outcome

Anticoagulation in patients with dilated cardiomyopathy, low ejection fraction, and sinus rhythm: back to the drawing board

Heart failure patients present an important thrombo-embolic risk, including symptomatic or silent peripheral arterial embolism, pulmonary embolism, and stroke. Patients in sinus rhythm who have concomitant depressed (< 35%) left ventricular ejection fraction have a 4% rate of embolic events. Several prospective randomized trials of anticoagulation in this group of patients were either underpowered or had a short period of follow-up. Even though in two studies warfarin had a slight advantage over aspirin (in the WATCH and WARCEF trials), it was at the cost of an increased risk in major hemorrhage. To decrease bleeding rates and to improve anticoagulant effect, new treatment strategies have to be tested. Novel anticoagulants (dabigatran, rivaroxaban, and apixaban) seem to be a promising alternative.

Silent brain infarction in the presence of systemic vascular disease

Objective

To determine the prevalence of asymptomatic brain ischaemic in the presence of vascular disease in other arterial territories.

Design

Studies up to January 2011 were identified through comprehensive search strategies. Arcsine transformation for meta-analysis was used to calculate the standardized mean difference (SMD) and 95% confidence intervals (CI).

Setting

A systematic review and meta-analysis were performed.

Participants

For each study, the proportion of patients positive for SBI in the presence of other systemic vascular disease was extracted and analyzed.

Main outcome measures

Using a random-effects model, a pooled effect estimate interpreted as a percentage prevalence of disease was calculated.

Results

SBI in the presence of acute ischaemic stroke was found in 23% (SMD 0.99; P < 0.001; 95% CI 0.88–1.10); a 35% prevalence was found in patients with coronary artery disease (SMD 1.26; P < 0.001; 95% CI 0.95–1.58); and a 14% prevalence in patients with peripheral artery disease (SMD 0.48; P < 0.002; 95% CI 0.42–0.54), although the data-set in the latter is smaller.

Conclusions

Patients with systemic vascular disease are at an increased risk of silent brain infarction.

Need for extensive diagnostic work-up for patients with lacunar stroke

OBJECTIVE

Small-vessel disease is the most frequent cause of lacunar stroke. The aims of this study were to evaluate: 1) alternative causes of lacunar stroke other than small-vessel disease; 2) functional outcome of lacunar strokes due to small vessel disease compared to lacunar strokes due to alternative causes.

METHODS

Consecutive patients with first-ever ischemic lacunar stroke were prospectively followed-up for at least 3 months. At discharge patients were divided into 2 groups: lacunar stroke due to small vessel disease (L-SVD) and lacunar stroke due to possible other etiologies (L-non SVD) (e. g. cardioembolism, atherosclerosis or other causes). Main outcome measures were the combined end point of death or disability (mRS >or= 3) and recurrent stroke at the end of follow-up.

RESULTS

535 patients with acute stroke were seen during the study period. Out of these, 196 patients (126 males) with a mean age of 71.6 years (SD = 10) had lacunar stroke. L-SVD was seen in 142 patients (72.4 %) and L-nonSVD in 54 patients (27.6 %). After 16.4 months, 12 patients had died (6.2%; annual mortality rate 4.4 %), 63 were disabled (32.5 %) and 27 had stroke recurrence (13.9%; annual recurrence rate 9.9 %). Forty-nine patients with L-SVD (34.7 %) and 26 with L-nonSVD (49%) had died or become disabled. Sixteen patients with L-SVD (11.3 %) and 11 with L-nonSVD (20.4 %) had stroke recurrence. On multivariate analysis, L-nonSVD (OR = 2.87, 95% CI 1.08-7.65; p = 0.034) and age (OR = 1.07, 95 % CI 1.02-1.12; p = 0.01) were associated to more severe outcome. L-nonSVD was independently associated with recurrence (OR = 5.03, 95% CI 1.54-16.44; p = 0.006).

CONCLUSIONS

Twenty-seven percent of patients with lacunar stroke have causes other than small vessel disease. These patients have a severe outcome in terms of recurrence,mortality or disability. These findings support the need for a comprehensive diagnostic work-up for patients with lacunar stroke.

High blood pressure and inflammation are associated with poor prognosis in lacunar infarctions

Lacunar infarction has long been considered to be associated with good prognosis, however a significant percentage of these patients remain functionally dependent. In this study we sought to investigate the factors associated with poor outcome in patients with lacunar infarction.

SUBJECTS AND METHODS

We have performed a secondary study in 113 patients with lacunar infarctions admitted within the first 24 h of symptom onset (mean age 70 years, 57.5% men). Blood pressure, body temperature, serum glucose levels, neurotransmitters and pro-inflammatory markers were measured at admission and during the first 72 h. Stroke severity was assessed by the Canadian Stroke Scale (CSS). Neuroimaging evaluation was performed at admission and between days 4 and 7. Poor functional outcome was considered as a Barthel index <85 at 3 months.

RESULTS

36 patients (31.9%) had poor outcome. Older age (p = 0.009), history of hypertension (p = 0.005), higher body temperature (p < 0.0001), systolic blood pressure (SBP) (p = 0.010), serum glucose (p = 0.002) and interleukin-6 (IL-6) (p < 0.0001) levels, as well as lower CSS score at admission (p < 0.0001) were all predictive factors of poor outcome in bivariate analyses. SBP at admission (OR 2.07, CI 95% 1.04-3.28, p = 0.015) was the only clinical predictor on multivariate analysis. When the logistic model was further adjusted for biomarkers of inflammation and excitotoxicity, IL-6 levels (OR 1.09, CI 95% 1.01-1.26, p = 0.003), but not SBP, was independently associated with poor outcome. This association persisted even after adjusting for potential predictors recorded during the first 72 h of hospitalization.

CONCLUSION

High SBP and IL-6 levels on admission may predict poor outcome in patients with lacunar infarction.

Evidence from biomarkers and surrogate endpoints

The use of physiological, anatomical, and other biological tests is commonplace in the practice of medicine. In neurology, objectively measured tests termed biomarkers (BMs) are playing an increasing role in diagnosis and management of disease, both in clinical practice and in experimental therapeutics. This article will discuss the various applications of BMs to the assessment of therapies for neurological diseases and will use examples from neurological diseases to elucidate the strengths and potential weaknesses of BMs. As the understanding of the pathophysiology of many neurological diseases has improved, new BMs have been developed, and efforts have been made to use these as proxies for clinical endpoints. A BM used in this manner is referred to as a surrogate endpoint (SE). There are many potential advantages and disadvantages of using SEs in the evaluation of new therapies, and these will be reviewed as well. Furthermore, the evidence required for the development of an SE and the nature of the evidence that can be derived from the use of BMs and SEs will be discussed.

Determinants of mortality in stroke patients with right brain damage

Stroke is the world's second leading cause of mortality and long-term disability. Damage to the nondominant right brain has distinct clinical characteristics. The resultant cardiovascular and autonomic dysfunction peculiar to right hemispheric stroke can adversely affect the short- and long-term outcome of stroke victims. Blood flow characteristics to the right hemisphere may also put the right brain at more risk for embolic and silent infarcts.

Silent and Symptomatic Infarcts on Cranial Computerized Tomography in Relation to Dementia and Mortality

BACKGROUND AND PURPOSE

Incidental findings of infarcts on brain imaging are common, but their clinical significance is not clear. We examined the prevalence of symptomatic and silent infarcts on cranial computerized tomography (cCT) and their relation to dementia and mortality in a representative sample of 239 85-year-olds living in Gothenburg Sweden.

METHODS

Information on stroke was obtained from an inpatient hospital linkage system, self-reports, and key informants. Dementia was defined according to the Diagnostic and Statistical Manual of Mental Disorders, 3rd revision. Cortical and lacunar infarcts were diagnosed on cCT.

RESULTS

The prevalence of cerebral infarcts was 17.1%, and half of those were clinically silent (8.6%). The frequency of dementia was increased in those with symptomatic (OR, 5.5; 95% CI, 2.1 to 14.1) and silent infarcts (OR, 2.7; 95% CI, 1.1 to 6.7). Infarcts increased the risk for dementia and its severity in women but not in men. The 3-year mortality rate was increased in those with symptomatic (OR, 4.0; 95% CI, 1.6 to 9.6) and silent infarcts (OR, 3.4; 95% CI, 1.4 to 8.5).

CONCLUSIONS

Almost one fifth of 85-year-olds have infarcts on cCT, and half of those are clinically silent. These infarcts are related to an increased rate of dementia and 3-year mortality. Cerebrovascular disease as a cause of dementia may be underrated because of silent infarcts. It has to be elucidated whether treatment of risk factors for stroke may reduce the consequences of silent infarcts.